The Clinical Trial Company (TCTC), a full-service contract research organisation (CRO) formed in the UK in 2002, has moved into new headquarters in Knutsford, Cheshire, citing “sustained growth” in all of its divisions.

“As a result of the hard work of our committed team, we have simply outgrown our existing offices over the past four years,” said director and co-founder Ewan Campbell. The new headquarters in Pickmere, Knutsford are designed to meet TCTC’s requirements over the next five years. The facility includes a training suite for use by The Clinical Training Company, the latest addition to the UK group.

TCTC was set up to fill a gap in the CRO sector for a company targeting “medium-sized clinical trials and novel products which did not have a classical road map to the market”, it noted. “The large CROs, for good business reasons, prioritise studies from the big pharmaceutical companies,” TCTC pointed out. “However, this approach may sometimes disadvantage their smaller clients who are equally keen to complete their clinical trials quickly.”

The UK company has regional offices in Toronto and Montreal, Canada, and in Sydney and Perth, Australia. TCTC has operating divisions covering all aspects of drug development, including The CRA Company, The Regulatory Affairs Company, The Clinical Training Company and the Clinical Quality Assurance Company.